The Immune Pharmaceuticals Inc. (IMNP) Set to Announce Quarterly Earnings on Thursday

Owen Stevens
Декабря 11, 2016

Immune Pharmaceuticals Inc. now has a P/E Ratio of N/A. Traders may also keep an eye on a company's PEG or price to earnings growth ratio. (NASDAQ:IMNP) opened at 0.178 on Wednesday. The Bid price in the last session was $0.18 x 10000 and the Ask price was $0.22 x 7400. The stock traded with the volume of 31.21 Million in the last trading session. The corporation holds 69.48 million outstanding shares and its 68.46 million shares were floated in the market. The most optimistic analyst sees the stock reaching $3 while the most conventional predicts the target price at $1. The biopharmaceutical company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.13).

Relative strength index (RSI-14) for Immune Pharmaceuticals Inc (NASDAQ:IMNP) is at 47.50.

2 number of analysts also provided their insight on Immune Pharmaceuticals Inc., where the Average Price Target for the stock is $2. Sell-side analysts covering the company are looking for the stock to go to $2.0000 within the next 52 weeks.

A look at performance overview of Immune Pharmaceuticals Inc. depicts that Performance (Week) is 14.15 percent while Performance Month is 6.07%. Out of rating recommendations 1 have given the stock a Buy while 1 recommend the stock as Outperform. Immune Pharmaceuticals Inc (NASDAQ:IMNP) shares were trading -78.30% below from the 52-week high mark of $0.87 and +21.73% above from the 52-week bottom of $0.16. The company's 50-day moving average is $0.24 and its 200 day moving average is $0.34.

Читайте также: Chip and Joanna Gaines Just Got Hit With a $1 Million Lawsuit

An important factor to consider when evaluating a stock's current and future value are the 52 week price high and low levels. The stock's day range was recorded between a low of $2.65 and a high $2.95. The stock established a negative trend of -11.48% in last week and indicated fall of -19.40% in previous month. Quarterly performance shows a value of -44.63% and Half Year Performance value stands at -60.67%.

The company has its Return on Assets (ROA) of -112.1 Percent. The company has a current PEG Ratio of 0.0000. Average true range (ATR-14) of the company sets at 0.04, along with its weekly and monthly volatility of 33.39%, 16.45% respectively.

A frequently used metric is a company's price to earnings ratio. Yearly performance of the stock has the value of -72.64 percent. A PEG Ratio below one may represent that the company is undervalued.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2019 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Other reports by

Discuss This Article